News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,115 Results
Type
Article (15083)
Company Profile (299)
Press Release (269725)
Multimedia
Podcasts (90)
Webinars (12)
Section
Business (79921)
Career Advice (164)
Deals (13371)
Drug Delivery (42)
Drug Development (50760)
Employer Resources (31)
FDA (5879)
Job Trends (5182)
News (145281)
Policy (10082)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (936)
Accelerated approval (24)
Adcomms (14)
Allergies (96)
Alliances (21771)
ALS (149)
Alzheimer's disease (1097)
Antibody-drug conjugate (ADC) (317)
Approvals (6119)
Artificial intelligence (316)
Autoimmune disease (186)
Automation (10)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (112)
Biotechnology (230)
Bladder cancer (114)
Brain cancer (54)
Breast cancer (379)
Cancer (3574)
Cardiovascular disease (273)
Career advice (149)
Career pathing (8)
CAR-T (241)
CDC (6)
Cell therapy (626)
Cervical cancer (20)
Clinical research (44289)
Collaboration (1342)
Company closure (2)
Compensation (680)
Complete response letters (51)
COVID-19 (1116)
CRISPR (97)
C-suite (677)
Cystic fibrosis (116)
Data (4994)
Denatured (18)
Depression (105)
Dermatology (41)
Diabetes (280)
Diagnostics (1415)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (235)
Drug pricing (51)
Drug shortages (3)
Duchenne muscular dystrophy (255)
Earnings (32217)
Editorial (28)
Employer branding (4)
Employer resources (29)
Events (52469)
Executive appointments (661)
FDA (7873)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (13)
Frontotemporal dementia (29)
Funding (1115)
Gene editing (202)
Generative AI (29)
Gene therapy (548)
GLP-1 (542)
Government (1169)
Grass and pollen (3)
Guidances (171)
Healthcare (6649)
HIV (24)
Huntington's disease (47)
IgA nephropathy (80)
Immunology and inflammation (218)
Immuno-oncology (66)
Indications (108)
Infectious disease (1255)
Inflammatory bowel disease (167)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (188)
Interviews (18)
IPO (7352)
IRA (13)
Job creations (868)
Job search strategy (130)
JPM (41)
Kidney cancer (9)
Labor market (26)
Layoffs (249)
Leadership (10)
Legal (1403)
Liver cancer (43)
Longevity (20)
Lung cancer (474)
Lymphoma (276)
Machine learning (29)
Management (7)
Manufacturing (448)
MASH (144)
Medical device (2688)
Medtech (2698)
Mergers & acquisitions (6700)
Metabolic disorders (825)
mRNA (131)
Multiple sclerosis (115)
NASH (14)
Neurodegenerative disease (285)
Neuropsychiatric disorders (76)
Neuroscience (2151)
Neurotech (1)
NextGen: Class of 2026 (2036)
Non-profit (872)
Now hiring (37)
Obesity (379)
Opinion (133)
Ovarian cancer (153)
Pain (121)
Pancreatic cancer (187)
Parkinson's disease (275)
Partnered (12)
Patents (352)
Patient recruitment (436)
Peanut (46)
People (26979)
Pharmaceutical (42)
Pharmacy benefit managers (6)
Phase 1 (15690)
Phase 2 (20600)
Phase 3 (12986)
Pipeline (4705)
Policy (99)
Postmarket research (853)
Preclinical (6635)
Press Release (30)
Prostate cancer (171)
Psychedelics (51)
Radiopharmaceuticals (262)
Rare diseases (788)
Real estate (1450)
Recruiting (12)
Regulatory (10267)
Reports (20)
Research institute (978)
Resumes & cover letters (20)
Rett syndrome (30)
RNA editing (23)
RSV (23)
Schizophrenia (137)
Series A (214)
Series B (152)
Service/supplier (1)
Sickle cell disease (85)
Special edition (19)
Spinal muscular atrophy (124)
Sponsored (16)
Startups (2019)
State (1)
Stomach cancer (5)
Supply chain (38)
Tariffs (19)
The Weekly (70)
Vaccines (373)
Venture capital (77)
Weight loss (203)
Women's health (38)
Worklife (2)
Date
Today (69)
Last 7 days (326)
Last 30 days (1557)
Last 365 days (17854)
2026 (5164)
2025 (18099)
2024 (20540)
2023 (22414)
2022 (26824)
2021 (27805)
2020 (23356)
2019 (16227)
2018 (11738)
2017 (13746)
2016 (11846)
2015 (14354)
2014 (10395)
2013 (7486)
2012 (7533)
2011 (7619)
2010 (7430)
Location
Africa (154)
Alabama (71)
Alaska (2)
Arizona (77)
Arkansas (6)
Asia (18468)
Australia (3162)
California (7830)
Canada (2039)
China (891)
Colorado (283)
Connecticut (288)
Delaware (266)
Europe (39715)
Florida (1008)
Georgia (231)
Hawaii (2)
Idaho (17)
Illinois (453)
India (41)
Indiana (185)
Iowa (8)
Japan (269)
Kansas (82)
Kentucky (11)
Louisiana (12)
Maine (12)
Maryland (813)
Massachusetts (6197)
Michigan (119)
Minnesota (280)
Mississippi (3)
Missouri (34)
Montana (17)
Nebraska (6)
Nevada (42)
New Hampshire (22)
New Jersey (1816)
New Mexico (13)
New York (1955)
North Carolina (913)
North Dakota (6)
Northern California (3910)
Ohio (198)
Oklahoma (11)
Oregon (23)
Pennsylvania (1444)
Puerto Rico (11)
Rhode Island (27)
South America (216)
South Carolina (12)
Southern California (3128)
Tennessee (48)
Texas (1045)
United States (25916)
Utah (108)
Virginia (161)
Washington D.C. (37)
Washington State (644)
West Virginia (1)
Wisconsin (50)
285,115 Results for "protagenic therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
March 10, 2026
·
3 min read
Press Releases
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
March 17, 2026
·
5 min read
Press Releases
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
November 27, 2025
·
3 min read
Press Releases
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
November 14, 2025
·
3 min read
Press Releases
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
August 24, 2025
·
3 min read
Press Releases
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
July 31, 2025
·
3 min read
Press Releases
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
August 22, 2025
·
2 min read
Press Releases
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
May 21, 2025
·
1 min read
Press Releases
Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split
April 29, 2025
·
5 min read
Business
Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results
Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a leader in biopharmaceutical innovation, today provided a corporate update and reported financial results for the fourth quarter and full year 2023.
April 1, 2024
·
7 min read
1 of 28,512
Next
